云南白药(000538) - 2025年12月11日投资者关系活动记录表

Group 1: Investor Relations Activity - The meeting was categorized as an analyst meeting and included one-on-one communication with various investment firms [2] - Participants included representatives from multiple investment firms and individual investors [2] Group 2: Meeting Details - The meeting took place on November 12, 2025, at the company's headquarters [2] - The main purpose of the meeting was to understand the company's production and operational status [2] Group 3: Attendees - Notable attendees included representatives from Jiangxi Zhifeng Consulting, Guangdong Zhenyuan Private Equity Fund, and other investment entities [2] - Company representatives included Zhang Yu, Yang Kexin, and Yu Yang from the investor relations management team [2]